{"id":"https://openalex.org/W3202437590","doi":"https://doi.org/10.1097/icl.0000000000000847","title":"Efficacy of the Systane iLux Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction After 1 Week and 1 Month: A Prospective Study","display_name":"Efficacy of the Systane iLux Thermal Pulsation System for the Treatment of Meibomian Gland Dysfunction After 1 Week and 1 Month: A Prospective Study","publication_year":2021,"publication_date":"2021-10-05","ids":{"openalex":"https://openalex.org/W3202437590","doi":"https://doi.org/10.1097/icl.0000000000000847","mag":"3202437590","pmid":"https://pubmed.ncbi.nlm.nih.gov/34620785","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8920001"},"language":"en","primary_location":{"id":"doi:10.1097/icl.0000000000000847","doi":"https://doi.org/10.1097/icl.0000000000000847","is_oa":true,"landing_page_url":"https://doi.org/10.1097/icl.0000000000000847","pdf_url":null,"source":{"id":"https://openalex.org/S204027754","display_name":"Eye & Contact Lens Science & Clinical Practice","issn_l":"0733-8902","issn":["0733-8902","1542-2321","1542-233X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye &amp; Contact Lens: Science &amp; Clinical Practice","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://doi.org/10.1097/icl.0000000000000847","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5056044942","display_name":"David J. Schanzlin","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David Schanzlin","raw_affiliation_strings":["Gordon Schanzlin New Vision (D.S.), San Diego, CA; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Total Vision (S.K.), LLC, San Diego, CA; Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; and University of Houston (M.A.B.), College of Optometry, Houston, TX","Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Gordon Schanzlin New Vision (D.S.), San Diego, CA; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Total Vision (S.K.), LLC, San Diego, CA; Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; and University of Houston (M.A.B.), College of Optometry, Houston, TX","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5032601290","display_name":"James P. Owen","orcid":"https://orcid.org/0000-0002-6043-1924","observed_orcids":["https://orcid.org/0000-0002-6043-1924"]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]},{"id":"https://openalex.org/I4210110630","display_name":"Gordon Schanzlin New Vision Institute","ror":"https://ror.org/02qzyds37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110630"]},{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"James P. Owen","raw_affiliation_strings":["Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","Gordon Schanzlin New Vision (D.S.), San Diego, CA","and University of Houston (M.A.B.), College of Optometry, Houston, TX","Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]},{"raw_affiliation_string":"Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","institution_ids":[]},{"raw_affiliation_string":"Gordon Schanzlin New Vision (D.S.), San Diego, CA","institution_ids":["https://openalex.org/I4210110630"]},{"raw_affiliation_string":"and University of Houston (M.A.B.), College of Optometry, Houston, TX","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Steve Klein","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]},{"id":"https://openalex.org/I4210110630","display_name":"Gordon Schanzlin New Vision Institute","ror":"https://ror.org/02qzyds37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110630"]},{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Steve Klein","raw_affiliation_strings":["Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","Gordon Schanzlin New Vision (D.S.), San Diego, CA","and University of Houston (M.A.B.), College of Optometry, Houston, TX","Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]},{"raw_affiliation_string":"Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","institution_ids":[]},{"raw_affiliation_string":"Gordon Schanzlin New Vision (D.S.), San Diego, CA","institution_ids":["https://openalex.org/I4210110630"]},{"raw_affiliation_string":"and University of Houston (M.A.B.), College of Optometry, Houston, TX","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014501603","display_name":"Thao N. Yeh","orcid":"https://orcid.org/0000-0001-6008-5278","observed_orcids":["https://orcid.org/0000-0001-6008-5278"]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]},{"id":"https://openalex.org/I4210110630","display_name":"Gordon Schanzlin New Vision Institute","ror":"https://ror.org/02qzyds37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110630"]},{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thao N. Yeh","raw_affiliation_strings":["Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","Gordon Schanzlin New Vision (D.S.), San Diego, CA","and University of Houston (M.A.B.), College of Optometry, Houston, TX","Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]},{"raw_affiliation_string":"Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","institution_ids":[]},{"raw_affiliation_string":"Gordon Schanzlin New Vision (D.S.), San Diego, CA","institution_ids":["https://openalex.org/I4210110630"]},{"raw_affiliation_string":"and University of Houston (M.A.B.), College of Optometry, Houston, TX","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012931561","display_name":"Mohinder M. Merchea","orcid":"https://orcid.org/0000-0002-3871-8849","observed_orcids":["https://orcid.org/0000-0002-3871-8849"]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]},{"id":"https://openalex.org/I4210110630","display_name":"Gordon Schanzlin New Vision Institute","ror":"https://ror.org/02qzyds37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110630"]},{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mohinder M. Merchea","raw_affiliation_strings":["Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","Gordon Schanzlin New Vision (D.S.), San Diego, CA","and University of Houston (M.A.B.), College of Optometry, Houston, TX","Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]},{"raw_affiliation_string":"Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","institution_ids":[]},{"raw_affiliation_string":"Gordon Schanzlin New Vision (D.S.), San Diego, CA","institution_ids":["https://openalex.org/I4210110630"]},{"raw_affiliation_string":"and University of Houston (M.A.B.), College of Optometry, Houston, TX","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5021419954","display_name":"Mark A. Bullimore","orcid":"https://orcid.org/0000-0002-6315-3720","observed_orcids":["https://orcid.org/0000-0002-6315-3720"]},"institutions":[{"id":"https://openalex.org/I4210086271","display_name":"Alcon (United States)","ror":"https://ror.org/000s8jb40","country_code":"US","type":"company","lineage":["https://openalex.org/I4210086271","https://openalex.org/I4210155258"]},{"id":"https://openalex.org/I4210110630","display_name":"Gordon Schanzlin New Vision Institute","ror":"https://ror.org/02qzyds37","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210110630"]},{"id":"https://openalex.org/I44461941","display_name":"University of Houston","ror":"https://ror.org/048sx0r50","country_code":"US","type":"education","lineage":["https://openalex.org/I44461941"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Mark A. Bullimore","raw_affiliation_strings":["Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","Gordon Schanzlin New Vision (D.S.), San Diego, CA","and University of Houston (M.A.B.), College of Optometry, Houston, TX","Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX","institution_ids":["https://openalex.org/I4210086271"]},{"raw_affiliation_string":"Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA","institution_ids":[]},{"raw_affiliation_string":"Gordon Schanzlin New Vision (D.S.), San Diego, CA","institution_ids":["https://openalex.org/I4210110630"]},{"raw_affiliation_string":"and University of Houston (M.A.B.), College of Optometry, Houston, TX","institution_ids":["https://openalex.org/I44461941"]},{"raw_affiliation_string":"Alcon Vision LLC (T.N.Y., M.M.M.), Fort Worth, TX; D. Schanzlin has received consulting fees from Refocus Group (Dallas, TX). J.P. Owen has been a consultant or received honorarium from ScienceBased Health and Alcon Vision, LLC. S. Klein has received honoraria or consulting fees from AMO, Alcon, CooperVision, J&J, Tear Film Innovations, SynergEyes, and Zeiss. He is not an equity holder in any ophthalmic industry companies. T.N. Yeh and M.M. Merchea are employees of Alcon Vision, LLC. M.A. Bullimore is a consultant for Alcon Research, Apellis, Arctic Vision, AsclepiX, CooperVision, CorneaGen, Essilor, Euclid Systems, Eyenovia, Genentech, Johnson & Johnson Vision, Lentechs, Novartis, Oculus, Paragon Vision Sciences, and Presbia.; Encinitas Ophthalmic Consulting (J.P.O.), Oceanside, CA; Gordon Schanzlin New Vision (D.S.), San Diego, CA; This is an open access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND), where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.; Total Vision (S.K.), LLC, San Diego, CA; University of Houston (M.A.B.), College of Optometry, Houston, TX.; e-mail: [email\u00a0protected]","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":["https://openalex.org/A5021419954"],"corresponding_institution_ids":["https://openalex.org/I4210086271","https://openalex.org/I4210110630","https://openalex.org/I44461941"],"apc_list":null,"apc_paid":null,"fwci":2.3774,"has_fulltext":false,"cited_by_count":14,"citation_normalized_percentile":{"value":0.88268232,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":90,"max":97},"biblio":{"volume":"48","issue":"4","first_page":"155","last_page":"161"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10997","display_name":"Ocular Surface and Contact Lens","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11521","display_name":"Salivary Gland Disorders and Functions","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2737","display_name":"Physiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10250","display_name":"Glaucoma and retinal disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/meibomian-gland-dysfunction","display_name":"meibomian gland dysfunction","score":0.9950000047683716},{"id":"https://openalex.org/keywords/thermal-pulses","display_name":"thermal pulses","score":0.7950000166893005},{"id":"https://openalex.org/keywords/meibography","display_name":"meibography","score":0.7960000038146973},{"id":"https://openalex.org/keywords/meibomian-gland-secretion","display_name":"meibomian gland secretion","score":0.9390000104904175},{"id":"https://openalex.org/keywords/dry-eye-disease","display_name":"dry eye","score":0.7630000114440918},{"id":"https://openalex.org/keywords/tear-film-break-up-time","display_name":"tear film break-up time","score":0.8040000200271606},{"id":"https://openalex.org/keywords/ocular-surface-disease","display_name":"ocular surface disease","score":0.8889999985694885},{"id":"https://openalex.org/keywords/speed-questionnaire","display_name":"SPEED questionnaire","score":0.7039999961853027},{"id":"https://openalex.org/keywords/ocular-surface-disease-index","display_name":"Ocular Surface Disease Index","score":0.9259999990463257},{"id":"https://openalex.org/keywords/treatment-efficacy","display_name":"treatment efficacy","score":0.6420000195503235},{"id":"https://openalex.org/keywords/meibography-guided-treatment","display_name":"meibography-guided treatment","score":0.48399999737739563}],"concepts":[{"id":"https://openalex.org/C2777165675","wikidata":"https://www.wikidata.org/wiki/Q1425513","display_name":"Meibomian gland","level":3,"score":0.8877464532852173},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7578743696212769},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.5783193111419678},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.5527269244194031},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.28992778062820435},{"id":"https://openalex.org/C2781302119","wikidata":"https://www.wikidata.org/wiki/Q48228","display_name":"Eyelid","level":2,"score":0.11003461480140686}],"mesh":[{"descriptor_ui":"D000080343","descriptor_name":"Meibomian Gland Dysfunction","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006979","descriptor_name":"Hyperthermia, Induced","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D008537","descriptor_name":"Meibomian Glands","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013666","descriptor_name":"Tears","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015352","descriptor_name":"Dry Eye Syndromes","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1097/icl.0000000000000847","doi":"https://doi.org/10.1097/icl.0000000000000847","is_oa":true,"landing_page_url":"https://doi.org/10.1097/icl.0000000000000847","pdf_url":null,"source":{"id":"https://openalex.org/S204027754","display_name":"Eye & Contact Lens Science & Clinical Practice","issn_l":"0733-8902","issn":["0733-8902","1542-2321","1542-233X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye &amp; Contact Lens: Science &amp; Clinical Practice","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8920001","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8920001","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye Contact Lens","raw_type":"Text"},{"id":"pmid:34620785","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/34620785","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye & contact lens","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1097/icl.0000000000000847","doi":"https://doi.org/10.1097/icl.0000000000000847","is_oa":true,"landing_page_url":"https://doi.org/10.1097/icl.0000000000000847","pdf_url":null,"source":{"id":"https://openalex.org/S204027754","display_name":"Eye & Contact Lens Science & Clinical Practice","issn_l":"0733-8902","issn":["0733-8902","1542-2321","1542-233X"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Eye &amp; Contact Lens: Science &amp; Clinical Practice","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":36,"referenced_works":["https://openalex.org/W145780728","https://openalex.org/W1166213834","https://openalex.org/W1711996954","https://openalex.org/W1982934791","https://openalex.org/W1984864129","https://openalex.org/W1993900282","https://openalex.org/W2034672829","https://openalex.org/W2046176994","https://openalex.org/W2048380539","https://openalex.org/W2063053088","https://openalex.org/W2076153412","https://openalex.org/W2091630088","https://openalex.org/W2091786916","https://openalex.org/W2096825552","https://openalex.org/W2111027666","https://openalex.org/W2126323789","https://openalex.org/W2223303194","https://openalex.org/W2279054906","https://openalex.org/W2313816167","https://openalex.org/W2327580620","https://openalex.org/W2433954454","https://openalex.org/W2487834907","https://openalex.org/W2560921608","https://openalex.org/W2566861944","https://openalex.org/W2605946318","https://openalex.org/W2622079263","https://openalex.org/W2767073127","https://openalex.org/W2788933616","https://openalex.org/W2791155054","https://openalex.org/W2802969275","https://openalex.org/W2806608783","https://openalex.org/W2884219388","https://openalex.org/W2971722633","https://openalex.org/W3005972662","https://openalex.org/W3048747167","https://openalex.org/W3116615068"],"related_works":["https://openalex.org/W4307977488","https://openalex.org/W967931286","https://openalex.org/W4214551766","https://openalex.org/W4296039295","https://openalex.org/W2096825552","https://openalex.org/W1711996954","https://openalex.org/W4411651433","https://openalex.org/W2326526630","https://openalex.org/W3005685634","https://openalex.org/W4386199556"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"assess":[2],"1-week":[3],"and":[4,46,94,98,108,140,156,161,164,173,191,200,203,206,212,245,257],"1-month":[5],"efficacy":[6,70,104],"of":[7,37,76,85,119],"Systane":[8,223],"iLux":[9,224],"thermal":[10,65,225],"pulsation":[11,66,226],"treatment":[12,67,227],"for":[13,78,228],"meibomian":[14,48,237],"gland":[15,49,238],"dysfunction":[16],"(MGD).":[17],"METHODS:":[18],"This":[19],"prospective,":[20],"nonrandomized,":[21],"open-label,":[22],"multicenter":[23],"study":[24],"enrolled":[25],"30":[26],"adult":[27],"patients":[28,120],"(60":[29],"eyes)":[30],"who":[31],"had":[32],"a":[33,83,232],"Standard":[34],"Patient":[35],"Evaluation":[36],"Eye":[38],"Dryness":[39],"(SPEED)":[40],"questionnaire":[41],"score":[42,52,74,130,186],"greater":[43],"than":[44,57],"6":[45],"total":[47],"secretion":[50],"(MGS)":[51],"equal":[53],"to":[54,135,142,153,158,171,175,188,197,210],"or":[55],"less":[56],"12":[58],"in":[59,231,236,241,247],"each":[60],"eye.":[61],"All":[62],"participants":[63],"received":[64],"bilaterally.":[68],"Primary":[69],"measures":[71,105],"included":[72],"MGS":[73,129,185],"(sum":[75],"grades":[77],"15":[79],"glands":[80],"graded":[81],"on":[82],"scale":[84],"0-3;":[86],"0":[87],"[no":[88],"secretion],":[89],"1":[90,125,181,255,258],"[inspissated],":[91],"2":[92],"[cloudy],":[93],"3":[95],"[clear":[96],"liquid])":[97],"tear":[99,242],"breakup":[100],"time":[101],"(TBUT).":[102],"Secondary":[103],"were":[106,220],"SPEED":[107,163,205],"Ocular":[109],"Surface":[110],"Disease":[111],"Index":[112],"(OSDI)":[113],"scores.":[114],"RESULTS:":[115],"The":[116],"mean":[117,128,147,162,184,194,204],"age":[118],"was":[121],"52.9\u00b111.9":[122],"years.":[123],"After":[124,180],"week,":[126],"the":[127,183],"improved":[131,149,167,187,196,209],"significantly":[132,150,168],"from":[133,151,169],"4.1\u00b13.1":[134],"15.8\u00b17.1":[136],"(right":[137],"eye,":[138,145],"OD)":[139],"3.7\u00b13.1":[141],"16.7\u00b17.6":[143],"(left":[144],"OS);":[146],"TBUT":[148,195],"4.9\u00b14.1":[152],"8.4\u00b13.6":[154],"(OD)":[155,190,199],"5.2\u00b14.2":[157],"8.9\u00b13.9":[159],"(OS);":[160,193,202],"OSDI":[165,207],"scores":[166,208],"16.1\u00b15.3":[170],"7.2\u00b16.1":[172],"45.2\u00b121.3":[174],"19.0\u00b116.8,":[176],"respectively":[177,214],"(all":[178,215],"P<0.001).":[179,216],"month,":[182],"18.3\u00b18.2":[189],"18.6\u00b17.3":[192],"9.7\u00b13.8":[198],"9.6\u00b13.5":[201],"7.0\u00b15.6":[211],"16.7\u00b114.5,":[213],"No":[217],"adverse":[218],"events":[219],"reported.":[221],"CONCLUSIONS:":[222],"MGD":[229],"resulted":[230],"statistically":[233],"significant":[234],"increase":[235],"secretion,":[239],"improvement":[240],"film":[243],"stability,":[244],"reduction":[246],"dry":[248],"eye":[249],"symptoms":[250],"as":[251,253],"early":[252],"both":[254],"week":[256],"month.":[259]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":4},{"year":2023,"cited_by_count":3},{"year":2022,"cited_by_count":4}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2021-10-11T00:00:00"}